(Q34565568)

3 August 2017

1 reference

title

Choosing the right medication for the treatment of alcoholism (English)

1 reference

3 August 2017

0 references

Helen Marie Pettinati

series ordinal

1

object named as

Helen M Pettinati

1 reference

3 August 2017

Amanda R Rabinowitz

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Current Psychiatry Reports

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

383-388

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-006-0040-0

3 August 2017

exact match

0 references

cites work

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

1 reference

12 December 2020

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

12 December 2020

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

12 December 2020

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

12 December 2020

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

1 reference

12 December 2020

A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.

1 reference

12 December 2020

Does disulfiram have a role in alcoholism treatment today?

1 reference

12 December 2020

Controlled trials of Antabuse in alcoholism: the importance of supervision and adequate dosage

1 reference

12 December 2020

Manual-guided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community.

1 reference

12 December 2020

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

12 December 2020

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

1 reference

12 December 2020

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

12 December 2020

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

1 reference

12 December 2020

Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism

1 reference

12 December 2020

Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism

1 reference

12 December 2020

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

12 December 2020

The status of disulfiram: a half of a century later

1 reference

12 December 2020

Antidepressant treatment of co-occurring depression and alcohol dependence

1 reference

12 December 2020

Patient Attitudes toward Treatment Predict Attendance in Clinical Pharmacotherapy Trials of Alcohol and Drug Treatment

1 reference

12 December 2020

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

1 reference

12 December 2020

Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat

1 reference

12 December 2020

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

12 December 2020

Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients

1 reference

12 December 2020

Participation in alcoholics anonymous: intended and unintended change mechanisms

1 reference

12 December 2020

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

1 reference

12 December 2020

The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

1 reference

12 December 2020

Adherence to pharmacotherapy in patients with alcohol and opioid dependence

1 reference

12 December 2020

Barriers to the use of medications to treat alcoholism.

1 reference

12 December 2020

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

12 December 2020

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

1 reference

12 December 2020

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

1 reference

12 December 2020

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

12 December 2020

10.1007/S11920-006-0040-0

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1019112142

0 references

1 reference